Shenzhen Weiguang Biological Products Co Ltd
SZSE:002880
Relative Value
The Relative Value of one Shenzhen Weiguang Biological Products Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 28.35 CNY, Shenzhen Weiguang Biological Products Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Shenzhen Weiguang Biological Products Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shenzhen Weiguang Biological Products Co Ltd
SZSE:002880
|
6.4B CNY | 5.6 | 28.1 | 24.1 | 24.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.5B USD | 6.6 | 168.3 | 16.3 | 23.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.2B USD | 5.4 | 25.5 | 14.7 | 14.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.1B USD | 6.3 | 22.7 | 15.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.1B USD | 10.1 | 32.1 | 23.6 | 24.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD | 5.5 | 17.7 | 14.9 | 17 | |
| AU |
|
CSL Ltd
ASX:CSL
|
73B AUD | 3.7 | 19.2 | 12.9 | 16.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR | 14.3 | 33.7 | 57.5 | 59.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |